NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

Is NVIDIA’s AI Chip Dominance Still Attractive After a 974% Three Year Surge?

Wondering if NVIDIA is still worth buying after its monster run, or if the real upside is already priced in? You are in the right place. The stock has pulled back about 6.6% over the last month despite being up 3.1% in the past week. It is still sitting on huge gains of 31.9% year to date and 28.1% over the last year, after a staggering 974.0% 3 year and 1305.7% 5 year climb. Recent headlines have centered on NVIDIA's dominant position in AI data center chips and expanding partnerships with...
NasdaqCM:IMTX
NasdaqCM:IMTXBiotechs

How Investors Are Reacting To Immatics (IMTX) $125 Million Follow-On Equity Offering

Immatics N.V. recently announced a follow-on equity offering, issuing 12,500,000 ordinary shares at US$10.00 each to raise about US$125,000,000 in gross proceeds, with the deal expected to close on December 8, 2025, subject to customary conditions. The involvement of Jefferies, Leerink Partners, and Cantor as joint book-running managers highlights the scale of the financing and the company’s access to capital markets. We’ll now examine how this sizeable capital raise, and the associated...
NasdaqGS:ACHC
NasdaqGS:ACHCHealthcare

Acadia Healthcare Company (ACHC) Is Down 10.1% After Litigation Cost Surge and COO Resignation - What's Changed

In recent days, Acadia Healthcare cut its 2025 earnings guidance after a third‑party review identified sharply higher patient‑related litigation and insurance costs, prompting a sizable increase in professional and general liability reserves. The company also flagged Medicaid volume and bad debt challenges alongside the abrupt resignation of its COO, adding operational and leadership uncertainty to its legal and financial pressures. Next, we’ll examine how these sharply higher litigation...
NYSE:CBL
NYSE:CBLRetail REITs

Reassessing CBL & Associates Properties (CBL) Valuation After New Buy Rating and $25 Million Buyback Plan

CBL & Associates Properties (CBL) just picked up a fresh Buy rating, along with a new 25 million dollar share repurchase plan, a combination that puts management confidence and investor interest under the spotlight. See our latest analysis for CBL & Associates Properties. The upbeat Buy rating and new repurchase plan arrive as momentum is already improving. A 1 month share price return of 16.23 percent and a 1 year total shareholder return of 23.86 percent suggest sentiment is steadily...
NasdaqGS:KALU
NasdaqGS:KALUMetals and Mining

Kaiser Aluminum (KALU): Revisiting Valuation After Zacks’ Strong Buy Rating and Upbeat Earnings Outlook

Fresh research coverage has put Kaiser Aluminum (KALU) in the spotlight after Zacks tagged it as a Strong Buy, highlighting its value metrics and earnings expectations compared with peers. See our latest analysis for Kaiser Aluminum. That optimism has been showing up in the trading tape too, with Kaiser Aluminum’s share price at $104.62 and a 90 day share price return of 35.13 percent feeding into a 48.88 percent year to date rise. Its 1 year total shareholder return of 35.27 percent suggests...
NYSE:CBT
NYSE:CBTChemicals

How Investors May Respond To Cabot (CBT) Missing Q4 Estimates And Flagging Mixed 2026 Outlook

Cabot recently reported that its Q4 fiscal 2025 earnings and sales declined from a year earlier and fell short of analyst estimates, reflecting softer demand conditions. The company also signaled that fiscal 2026 may remain challenging for its Reinforcement Materials business, even as it expects profit growth in Performance Chemicals led by Battery Materials and other growth areas. We’ll now examine how weaker Reinforcement Materials trends but improving Performance Chemicals prospects shape...
NasdaqGM:SHLS
NasdaqGM:SHLSElectrical

Shoals Technologies Group (SHLS): Evaluating Valuation After a Strong 1-Year Share Price Rebound

Shoals Technologies Group (SHLS) has quietly outpaced much of the clean energy space this year, with the stock up roughly 33% year to date and around 77% over the past year. See our latest analysis for Shoals Technologies Group. At a share price of $8.03, Shoals has given investors a solid boost, with a roughly 33% year to date share price return and a 77% total shareholder return over the past year. This suggests momentum is still very much on its side. If Shoals has caught your eye, this...
NasdaqGS:PDD
NasdaqGS:PDDMultiline Retail

Is It Too Late to Consider PDD Holdings After Strong Cash Flow and Global Growth?

Wondering if PDD Holdings is still a bargain or if the easy money has already been made? You are not alone. This stock has quietly become one of the most hotly debated value stories in Chinese tech. Despite some sharp swings lately, including a 1.3% gain over the last week, a 13.7% pullback over the last month, and a still solid 21.4% gain year to date, long term holders are sitting on a 31.1% 3 year return and 17.7% over the last year. Those moves have played out against a backdrop of...
NasdaqCM:MVST
NasdaqCM:MVSTMachinery

Microvast (MVST): Assessing Valuation as Škoda Partnership Highlights Growing Commercial Traction in Battery Technology

Microvast Holdings (MVST) is back on investors’ radar after fresh commentary highlighted growing commercial traction for its battery technology, including deployments with industrial partners like Škoda that underscore rising market validation. See our latest analysis for Microvast Holdings. That traction is starting to show up in the numbers, too, with the share price at $3.75 and a powerful 90 day share price return of 46.48 percent feeding into a 1 year total shareholder return above 200...
NYSE:TXT
NYSE:TXTAerospace & Defense

Textron (TXT) Valuation Check After Steady 10% Year-to-Date Share Price Gain

Textron (TXT) has quietly outperformed the broader market this year, and that steady climb has investors asking a simple question: does the current share price still leave meaningful upside on the table? See our latest analysis for Textron. With the share price now at $83.47 and a solid year to date share price return of just over 10 percent, Textron’s gains look more like a steady rerating as investors warm to its improving growth profile rather than a speculative spike. Multi year total...
NYSE:MHK
NYSE:MHKConsumer Durables

Mohawk Industries (MHK): A Fresh Look at Valuation After Recent Share Price Weakness

Mohawk Industries (MHK) has been on a choppy ride lately, with the stock slipping over the week but roughly flat for the month. That mix sets up an interesting value versus momentum debate. See our latest analysis for Mohawk Industries. Over the past year, Mohawk Industries has seen its share price return slide, reflected in a recent 7 day share price return of negative 4.5 percent and a 1 year total shareholder return of negative 15.5 percent, signaling that momentum is still fading despite...
NasdaqGS:AGYS
NasdaqGS:AGYSSoftware

Does Agilysys Justify Its Premium Valuation After a 218% Five Year Surge?

Wondering if Agilysys at around $126 a share is a hidden opportunity or just fully priced in already? You are not alone, as this stock has been quietly attracting valuation minded investors. Over the very short term it has been a bit choppy, up 2.5% in the last week but roughly flat over 30 days, while still sitting on a 106.9% gain over 3 years and 217.7% over 5 years, even though it is down 2.8% year to date and 5.7% over the last year. Recent attention has centered on Agilysys as a niche...
NasdaqGM:RPD
NasdaqGM:RPDSoftware

Should Rapid7’s HITRUST Compliance Partnership Shift the Risk Calculus for RPD Investors?

In early December 2025, HITRUST and Rapid7 announced a partnership integrating Rapid7’s Surface Command platform with the HITRUST assurance framework to automate continuous compliance and strengthen cyber resilience for customers. A particularly important angle is how this integration could shift customers away from manual, point-in-time audits toward ongoing, evidence-based validation that also supports lower cyber insurance costs. We’ll now explore how this move toward continuous,...
NYSE:VOYG
NYSE:VOYGAerospace & Defense

Has Voyager Technologies Run Ahead of Itself After Recent Sensing and Automation Partnerships?

Wondering if Voyager Technologies at $23.75 is a beaten down bargain or a value trap? This article will walk you through what the numbers are really saying about the stock. Despite being down 57.9% year to date and 9.7% over the last month, the share price has bounced 5.6% in the past week, hinting that some investors might be testing the waters again. Recent headlines have focused on Voyager Technologies doubling down on next generation sensing and automation partnerships, as well as...
NasdaqGM:MDB
NasdaqGM:MDBIT

MongoDB (MDB): Reassessing Valuation After Strong Q3 Beat, Atlas Momentum and Raised Full-Year Guidance

MongoDB (MDB) just turned a strong quarter into a bigger story, with Atlas doing most of the heavy lifting and management lifting guidance. That combination, plus upbeat analyst commentary, is exactly what pushed the stock higher. See our latest analysis for MongoDB. Those Q3 numbers and higher guidance have come on top of an already strong run, with a roughly 67% year to date share price return and a three year total shareholder return above 100%. This signals that momentum and confidence...
NYSE:KGS
NYSE:KGSEnergy Services

What Kodiak Gas Services (KGS)'s EQT Exit and Board Power Shift Means For Shareholders

In early December 2025, Frontier TopCo Partnership, an affiliate of EQT Infrastructure funds, completed an underwritten secondary sale of 9,762,573 Kodiak Gas Services shares at US$34.60 each, raising about US$335.50 million, with Kodiak itself neither issuing new stock nor receiving any proceeds. The sale removes EQT as a shareholder and ends its board nomination rights, potentially reshaping Kodiak’s governance and future decision-making power balance. We’ll now examine how EQT’s full exit...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Is Zscaler’s Expanding AWS and Zero Trust Ecosystem Altering The Investment Case For Zscaler (ZS)?

In recent weeks, Peraton, Orca Security, and TPx have each announced expanded collaborations with Zscaler, while Zscaler also received major AWS Marketplace Partner of the Year honors tied to more than US$1.00 billion in AWS Marketplace sales. Together, these developments highlight how Zscaler’s Zero Trust and cloud-native security platform is increasingly embedded in critical infrastructure, multicloud, and managed SASE offerings across government and enterprise customers. We’ll now examine...
NYSE:AMPX
NYSE:AMPXElectrical

A look at Amprius Technologies’ valuation after Nokia selects its batteries for next‑gen drone networks

Nokia’s decision to use Amprius Technologies (AMPX) SiCore cells in its next generation drone networks puts a real world spotlight on the battery maker’s technology and its positioning in advanced UAV markets. See our latest analysis for Amprius Technologies. The Nokia win lands at a time when momentum in Amprius’ share price has been powerful, with a 90 day share price return of 71.31 percent and year to date share price return of 325.87 percent. The 1 year total shareholder return of 494.15...
NYSE:BROS
NYSE:BROSHospitality

How Investors Are Reacting To Dutch Bros (BROS) Raised 2025 Guidance And Strong Same-Store Sales

Dutch Bros recently reported robust third-quarter 2025 results, including revenue growth of 25% year over year and system-wide same-store sales growth of 5.7%, and raised its 2025 revenue guidance while continuing to expand its U.S. store footprint and digital platform. These developments, alongside an ongoing food program rollout and enhanced Order Ahead adoption, have prompted upbeat analyst commentary that emphasizes Dutch Bros’ execution on transaction growth, margins, and long-term unit...
NasdaqGS:APLS
NasdaqGS:APLSBiotechs

Why Apellis Pharmaceuticals (APLS) Is Up 10.9% After Positive EMPAVELI VALIANT Kidney Data And FDA Nod

Apellis Pharmaceuticals recently reported positive Phase 3 VALIANT results for EMPAVELI in C3 glomerulopathy and primary IC-MPGN, published in The New England Journal of Medicine, following its July 2025 FDA approval for patients aged 12 and older. The data show a meaningful reduction in proteinuria, stabilization of kidney function, and substantial clearance of C3 deposits, potentially strengthening EMPAVELI’s clinical profile and supporting broader physician confidence in complement...
NYSE:EVEX
NYSE:EVEXAerospace & Defense

Eve Holding (EVEX) Is Up 23.1% After Selecting BETA Motors For eVTOL Fleet Scale-Up

Eve Air Mobility recently selected BETA Technologies to supply electric pusher motors for its conforming prototypes and production eVTOL aircraft, supporting a backlog of 2,800 vehicles and a potential US$1.00 billion supply opportunity over 10 years. This agreement materially strengthens Eve’s propulsion architecture and supply chain as it works toward bringing its next-generation eVTOLs into commercial service. We’ll now examine how partnering with BETA Technologies for electric motors...
NYSE:SPR
NYSE:SPRAerospace & Defense

Spirit AeroSystems (SPR): Revisiting Valuation After Recent Share Price Rebound

Market context and recent move Spirit AeroSystems Holdings (SPR) has been grinding higher recently, with the stock up about 11% over the past month as investors reassess its recovery prospects despite ongoing losses and a challenging aerospace supply chain backdrop. See our latest analysis for Spirit AeroSystems Holdings. Zooming out, the 17.8% year to date share price return and 22.6% one year total shareholder return suggest momentum is gradually rebuilding as investors warm to Spirit...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

How Twin FDA Breakthrough Therapy Wins Could Impact Ionis Pharmaceuticals (IONS) Investors

In early December 2025, Ionis Pharmaceuticals announced that the FDA granted Breakthrough Therapy designation to zilganersen for Alexander disease and to olezarsen for severe hypertriglyceridemia, both supported by pivotal trials showing clinically meaningful benefits and favorable safety. These twin Breakthrough Therapy designations underscore Ionis’ RNA-targeted platform as a potential source of first-in-class treatments across both ultra-rare neurology and broader cardiometabolic...
NYSE:SKY
NYSE:SKYConsumer Durables

Will Champion Homes’ New CFO Shift Its Capital Allocation Playbook in Meaningful Ways for SKY?

Champion Homes, Inc. recently announced that former WK Kellogg Co CFO Dave McKinstray will become its Chief Financial Officer, Executive Vice President and Treasurer on January 12, 2026, succeeding long-serving finance leader Laurie Hough, who will stay until May 31, 2026 to support the handover. This leadership transition brings in a finance executive with deep experience in manufacturing, consumer products and risk management, potentially influencing how Champion balances growth...